Repertoire Partners LP bought a new stake in Integral Ad Science Holding Corp. (NASDAQ:IAS – Free Report) in the third quarter, Holdings Channel.com reports. The firm bought 155,000 shares of the company’s stock, valued at approximately $1,676,000. Integral Ad Science makes up about 1.9% of Repertoire Partners LP’s holdings, making the stock its 9th biggest position.
A number of other hedge funds have also modified their holdings of the business. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in Integral Ad Science during the second quarter worth about $4,724,000. Nisa Investment Advisors LLC increased its position in Integral Ad Science by 449,805.3% during the second quarter. Nisa Investment Advisors LLC now owns 427,410 shares of the company’s stock worth $4,154,000 after purchasing an additional 427,315 shares during the last quarter. abrdn plc increased its position in Integral Ad Science by 12.5% during the third quarter. abrdn plc now owns 2,147,656 shares of the company’s stock worth $23,216,000 after purchasing an additional 237,930 shares during the last quarter. Invenomic Capital Management LP increased its position in Integral Ad Science by 57.4% during the third quarter. Invenomic Capital Management LP now owns 585,309 shares of the company’s stock worth $6,327,000 after purchasing an additional 213,488 shares during the last quarter. Finally, Rice Hall James & Associates LLC acquired a new stake in Integral Ad Science during the third quarter worth about $1,795,000. 95.78% of the stock is currently owned by institutional investors and hedge funds.
Integral Ad Science Trading Down 1.9 %
NASDAQ IAS opened at $11.11 on Thursday. The firm has a 50 day simple moving average of $11.11 and a 200-day simple moving average of $10.61. The company has a debt-to-equity ratio of 0.07, a quick ratio of 3.71 and a current ratio of 3.71. Integral Ad Science Holding Corp. has a one year low of $7.98 and a one year high of $17.53. The firm has a market cap of $1.81 billion, a price-to-earnings ratio of 55.55, a PEG ratio of 1.59 and a beta of 1.45.
Insider Buying and Selling
In related news, CEO Lisa Utzschneider sold 10,481 shares of Integral Ad Science stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $10.11, for a total value of $105,962.91. Following the completion of the transaction, the chief executive officer now owns 239,709 shares in the company, valued at $2,423,457.99. The trade was a 4.19 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Tania Secor sold 6,643 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $11.24, for a total transaction of $74,667.32. Following the sale, the chief financial officer now directly owns 251,366 shares in the company, valued at approximately $2,825,353.84. The trade was a 2.57 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 23,006 shares of company stock worth $240,296 over the last 90 days. 2.00% of the stock is owned by insiders.
Analysts Set New Price Targets
IAS has been the subject of several recent analyst reports. Piper Sandler cut their price objective on shares of Integral Ad Science from $18.00 to $16.00 and set an “overweight” rating for the company in a research report on Wednesday, November 13th. Craig Hallum cut their price objective on shares of Integral Ad Science from $18.00 to $16.00 and set a “buy” rating for the company in a research report on Wednesday, November 13th. Truist Financial dropped their price target on shares of Integral Ad Science from $18.00 to $16.00 and set a “buy” rating for the company in a research report on Wednesday, November 13th. Oppenheimer dropped their price target on shares of Integral Ad Science from $20.00 to $18.00 and set an “outperform” rating for the company in a research report on Wednesday, November 13th. Finally, Benchmark reiterated a “hold” rating on shares of Integral Ad Science in a research report on Thursday, November 14th. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $15.70.
Get Our Latest Research Report on IAS
About Integral Ad Science
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Read More
- Five stocks we like better than Integral Ad Science
- Differences Between Momentum Investing and Long Term Investing
- Tesla Poised to Hit Record Highs This Holiday Season
- Comparing and Trading High PE Ratio Stocks
- The Salesforce Rally is Just Getting Started: Here’s Why
- Transportation Stocks Investing
- 3 Chip and Data Center Stocks That Can Keep Rising in 2025
Want to see what other hedge funds are holding IAS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integral Ad Science Holding Corp. (NASDAQ:IAS – Free Report).
Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.